Effect of CP-778,875 on HDL-C in Subjects With Abnormal Lipid Levels and Type 2 Diabetes.
Clinical trial NCT00326326 · COMPLETED
Trial details
- NCT number
- NCT00326326
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-07-01
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.